Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V N Bagadia

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Progress in Neuro-Psychopharmacology|January 1, 1979
Treatment of mental disorders in IndiaV N Bagadia, L P Shah, P V Pradhan, et al.
Journal of Postgraduate Medicine|January 1, 1971
High doses of chlorpromazine and trifluoperazine in the treatment of patients suffering from schizophreniaV N Bagadia, P C Shastri, K P Dave, et al.
Indian Journal of Psychiatry|September 20, 2011
Death, dying and near death experienceA R Singh, V N Bagadia, P V Pradhan, et al.
Neurology India|December 1, 1973
A study of the effects of hospitalization on schizophrenic symptomatologyV N Bagadia, H N Ghadiali, P V Pradhan, et al.
Indian Journal of Psychiatry|November 8, 2011
Evaluation of cognitive effects of ect (preliminary observations)V N Bagadia, L P Shah, P V Pradhan, et al.
The Journal of the Association of Physicians of India|October 1, 1983
A double blind controlled study of ECT vs chlorpromazine in schizophreniaV N Bagadia, R R Abhyankar, J Doshi, et al.
Neuropsychobiology|January 1, 1979
Knowledge and technology needed for further development of mental health programmesV N Bagadia, L Eisenberg, M O Olatawura, et al.
Indian Journal of Psychiatry|September 20, 2011
Value of the general health questionnaire in detecting psychiatric morbidity in a general hospital out-patient populationV N Bagadia, K S Ayyar, P D Lakdawala, et al.
Psychopharmacology Bulletin|January 1, 1983
Report from a World Health Organization (WHO) Collaborative Centre for Psychopharmacology in India. Survey of antipsychotic drugs useM T Gada, B R Agrawal, P V Pradhan, et al.
Indian Journal of Psychiatry|August 18, 2011
Lithium in aggressionV N Bagadia, P D Lakdawala, P V Pradhan, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Progress in Neuro-Psychopharmacology|January 1, 1979
Treatment of mental disorders in IndiaV N Bagadia, L P Shah, P V Pradhan, et al.
Journal of Postgraduate Medicine|January 1, 1971
High doses of chlorpromazine and trifluoperazine in the treatment of patients suffering from schizophreniaV N Bagadia, P C Shastri, K P Dave, et al.
Indian Journal of Psychiatry|September 20, 2011
Death, dying and near death experienceA R Singh, V N Bagadia, P V Pradhan, et al.
Neurology India|December 1, 1973
A study of the effects of hospitalization on schizophrenic symptomatologyV N Bagadia, H N Ghadiali, P V Pradhan, et al.
Indian Journal of Psychiatry|November 8, 2011
Evaluation of cognitive effects of ect (preliminary observations)V N Bagadia, L P Shah, P V Pradhan, et al.
The Journal of the Association of Physicians of India|October 1, 1983
A double blind controlled study of ECT vs chlorpromazine in schizophreniaV N Bagadia, R R Abhyankar, J Doshi, et al.
Neuropsychobiology|January 1, 1979
Knowledge and technology needed for further development of mental health programmesV N Bagadia, L Eisenberg, M O Olatawura, et al.
Indian Journal of Psychiatry|September 20, 2011
Value of the general health questionnaire in detecting psychiatric morbidity in a general hospital out-patient populationV N Bagadia, K S Ayyar, P D Lakdawala, et al.
Psychopharmacology Bulletin|January 1, 1983
Report from a World Health Organization (WHO) Collaborative Centre for Psychopharmacology in India. Survey of antipsychotic drugs useM T Gada, B R Agrawal, P V Pradhan, et al.
Indian Journal of Psychiatry|August 18, 2011
Lithium in aggressionV N Bagadia, P D Lakdawala, P V Pradhan, et al.
Pageof 3